Like Qu

2.6k total citations
78 papers, 2.1k citations indexed

About

Like Qu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Like Qu has authored 78 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 27 papers in Oncology and 14 papers in Immunology. Recurrent topics in Like Qu's work include Protein Tyrosine Phosphatases (13 papers), Glycosylation and Glycoproteins Research (10 papers) and Galectins and Cancer Biology (9 papers). Like Qu is often cited by papers focused on Protein Tyrosine Phosphatases (13 papers), Glycosylation and Glycoproteins Research (10 papers) and Galectins and Cancer Biology (9 papers). Like Qu collaborates with scholars based in China, Ethiopia and United States. Like Qu's co-authors include Chengchao Shou, Antonis E. Koromilas, Lin Meng, Dionissios Baltzis, Yong Han, Xiaolu Yang, Jian Wu, Jun Tang, Olivier Pluquet and Lin Meng and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Like Qu

78 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Like Qu China 28 1.4k 609 405 269 265 78 2.1k
Denise Perez Brazil 16 1.4k 1.0× 753 1.2× 413 1.0× 308 1.1× 250 0.9× 21 2.1k
Nai Yang Fu Singapore 26 1.5k 1.0× 920 1.5× 390 1.0× 256 1.0× 237 0.9× 43 2.3k
Subbareddy Maddika India 28 2.1k 1.5× 596 1.0× 367 0.9× 272 1.0× 342 1.3× 48 2.9k
Yi‐Ren Hong Taiwan 25 1.5k 1.0× 381 0.6× 269 0.7× 261 1.0× 380 1.4× 110 2.2k
Heimo Strohmaier Austria 22 1.9k 1.3× 686 1.1× 781 1.9× 211 0.8× 415 1.6× 33 2.7k
Shuang Liu China 25 1.3k 0.9× 343 0.6× 488 1.2× 193 0.7× 184 0.7× 83 2.2k
Howard O. Fearnhead Ireland 26 2.0k 1.4× 489 0.8× 327 0.8× 496 1.8× 235 0.9× 53 2.6k
Stéphanie Plenchette France 22 1.7k 1.2× 465 0.8× 472 1.2× 622 2.3× 217 0.8× 34 2.3k

Countries citing papers authored by Like Qu

Since Specialization
Citations

This map shows the geographic impact of Like Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Like Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Like Qu more than expected).

Fields of papers citing papers by Like Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Like Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Like Qu. The network helps show where Like Qu may publish in the future.

Co-authorship network of co-authors of Like Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Like Qu. A scholar is included among the top collaborators of Like Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Like Qu. Like Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Caiyun, Meng Lin, Lixin Wang, et al.. (2025). Gamma-synuclein drives bevacizumab resistance in colorectal cancer via VEGFR2 activation and angiogenesis. Drug Resistance Updates. 84. 101299–101299. 1 indexed citations
2.
Zhao, Chuanke, Lixin Wang, Lin Meng, et al.. (2022). A multi-targeting natural product, aiphanol, inhibits tumor growth and metastasis.. PubMed. 12(11). 4930–4953. 5 indexed citations
3.
Min, Li, Cheng Zhang, Like Qu, et al.. (2017). Gene regulatory pattern analysis reveals essential role of core transcriptional factors’ activation in triple-negative breast cancer. Oncotarget. 8(13). 21938–21953. 13 indexed citations
4.
Huang, Dong‐Sheng, Hongying Duan, Hao Huang, et al.. (2016). Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition. Scientific Reports. 6(1). 20502–20502. 101 indexed citations
5.
Liu, Caiyun, Chonghua Hao, Qinghai Wang, et al.. (2016). Urine gamma-synuclein as a biomarker for the diagnosis of bladder cancer. Oncotarget. 7(28). 43432–43441. 18 indexed citations
6.
Min, Li, Cheng Zhang, Xiaofan Li, et al.. (2016). Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients. BMC Cancer. 16(1). 717–717. 6 indexed citations
7.
Qu, Like, Lixin Wang, Xingxin Yang, et al.. (2015). Sarsaparilla ( Smilax Glabra Rhizome) Extract Inhibits Cancer Cell Growth by S Phase Arrest, Apoptosis, and Autophagy via Redox-Dependent ERK1/2 Pathway. Cancer Prevention Research. 8(5). 464–474. 14 indexed citations
8.
Zhao, Chuanke, Jianzhi Zhang, Qin Feng, et al.. (2015). Fibrinogen‐derived fibrinostatin inhibits tumor growth through anti‐angiogenesis. Cancer Science. 106(11). 1596–1606. 21 indexed citations
9.
Huang, Hao, Yong Han, Cheng Zhang, et al.. (2015). HNRNPC as a candidate biomarker for chemoresistance in gastric cancer. Tumor Biology. 37(3). 3527–3534. 57 indexed citations
10.
Chang, Xiaohong, Caiyun Liu, Lin Meng, et al.. (2015). Prognostic value and characterization of the ovarian cancer-specific antigen CA166-9. International Journal of Oncology. 47(4). 1405–1415. 8 indexed citations
11.
Zhang, Cheng, Wei Tian, Lin Meng, Like Qu, & Chengchao Shou. (2015). PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis. Journal of Molecular Medicine. 94(4). 401–415. 33 indexed citations
12.
Duan, Hongying, Ling Chen, Like Qu, et al.. (2014). Mycoplasma Hyorhinis Infection Promotes NF- κ B–Dependent Migration of Gastric Cancer Cells. Cancer Research. 74(20). 5782–5794. 39 indexed citations
13.
Duan, Hongying, Like Qu, & Chengchao Shou. (2014). Activation of EGFR-PI3K-AKT signaling is required for Mycoplasma hyorhinis-promoted gastric cancer cell migration. Cancer Cell International. 14(1). 135–135. 36 indexed citations
14.
Xie, Wei, Qin Feng, Bin Dong, et al.. (2012). Transcriptional Regulation of PES1 Expression by c-Jun in Colon Cancer. PLoS ONE. 7(7). e42253–e42253. 35 indexed citations
15.
Xing, Xiaofang, et al.. (2009). [Construction and expression of PRL-3 plasmid with C104S point mutation and CAAX deletion].. PubMed. 41(5). 516–20. 2 indexed citations
16.
Baltzis, Dionissios, Olivier Pluquet, Andreas I. Papadakis, et al.. (2007). The eIF2α Kinases PERK and PKR Activate Glycogen Synthase Kinase 3 to Promote the Proteasomal Degradation of p53. Journal of Biological Chemistry. 282(43). 31675–31687. 96 indexed citations
17.
Hu, Shimin, et al.. (2006). CIAP2 Inhibits Anigen Receptor Signaling by Targeting Bcl10 for Degredation. Cell Cycle. 5(13). 1438–1442. 18 indexed citations
18.
Qu, Like & Antonis E. Koromilas. (2004). Control of Tumor Suppressor p53 Function by Endoplasmic Reticulum Stress. Cell Cycle. 3(5). 565–568. 16 indexed citations
19.
Gao, Pujun, et al.. (2003). A possible receptor for beta 2 glycoprotein I on the membrane of hepatoma cell line smmc7721.. PubMed. 116(9). 1308–11. 2 indexed citations
20.
Huang, Shirley, et al.. (2003). Protein kinase inhibitor 2-aminopurine overrides multiple genotoxic stress-induced cellular pathways to promote cell survival. Oncogene. 22(24). 3721–3733. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026